Document is current

Any future updates will be listed below

Correction: Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway

Crossref DOI link: https://doi.org/10.1186/s13046-023-02818-7

Published Online: 2023-09-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark